Prostate cancer cell proliferation is strongly reduced by the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in vitro on human cell lines and primary cultures.

MLA

Vicentini, Carlo, et al. “Prostate Cancer Cell Proliferation Is Strongly Reduced by the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor ZD1839 in Vitro on Human Cell Lines and Primary Cultures.” Journal of Cancer Research and Clinical Oncology, vol. 129, no. 3, Mar. 2003, pp. 165–74. EBSCOhost, https://doi.org/10.1007/s00432-003-0420-3.

APA

Vicentini, C., Festuccia, C., Gravina, G. L., Angelucci, A., Marronaro, A., & Bologna, M. (2003). Prostate cancer cell proliferation is strongly reduced by the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in vitro on human cell lines and primary cultures. Journal of Cancer Research and Clinical Oncology, 129(3), 165–174. https://doi.org/10.1007/s00432-003-0420-3

Chicago

Vicentini, Carlo, Claudio Festuccia, Giovanni Luca Gravina, Adriano Angelucci, Angelo Marronaro, and Mauro Bologna. 2003. “Prostate Cancer Cell Proliferation Is Strongly Reduced by the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor ZD1839 in Vitro on Human Cell Lines and Primary Cultures.” Journal of Cancer Research and Clinical Oncology 129 (3): 165–74. doi:10.1007/s00432-003-0420-3.